Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leckie, M. J
Right arrow Articles by Hansel, T. T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leckie, M. J
Right arrow Articles by Hansel, T. T
Thorax 2000;55:471-477 ( June )

Automated quantitation of circulating neutrophil and eosinophil activation in asthmatic patients

Margaret J Leckiea, Shannon A Bryana, Jamey Khana, Ann Dewarb, Sarah L Aikmana, Jennifer McGratha, David A Okronglyc, John F Burmand, Peter J Barnese, Trevor T Hansela

a National Heart and Lung Institute (NHLI), Royal Brompton Clinical Studies Unit, Royal Brompton Hospital, London SW3 6HP, UK, b Electron Microscopy Unit, Royal Brompton Hospital, London SW3 6HP, UK, c Bayer Diagnostics, Tarrytown, New York 10591-5097, USA, d Department of Haematology, Royal Brompton Hospital, London SW3 6HP, UK, e Department of Thoracic Medicine, NHLI, Imperial College School of Medicine, London SW3 6LY, UK

Correspondence to: Dr M J Leckie email: m.leckie{at}ic.ac.uk

Received 5 July 1999; Returned to authors 27 October 1999; Revised version received 14 January 2000; Accepted for publication 10 February 2000

BACKGROUND---Asthma has been associated with eosinophil activation, measured in serum, sputum, bronchoalveolar lavage (BAL) fluid, and urine. A whole blood automated method was developed to assess eosinophil and neutrophil activity in terms of peroxidase content and cell morphology using the Bayer haematology analyser. The method was applied to an in vitro stimulation model when fMLP was added to whole blood and the samples were then analysed for changes in granularity and shape. In addition, cells stimulated with interleukin (IL)-8 were examined by electron microscopy.
METHODS---A cross sectional analysis was performed on venous blood from non-atopic, non-asthmatic normal subjects (n = 37), mild (n = 46) and symptomatic (n = 22) asthmatic patients on inhaled beta 2 agonist only, and more severe asthmatic patients (n = 17) on inhaled and oral corticosteroid therapy. Samples were analysed by the haematology analyser and peroxidase leucograms gated using the WinMDI software program.
RESULTS---There were significant differences in the amount of light scatter by the neutrophil populations in the symptomatic (p = 0.007) and severe asthmatic (p = 0.0001) groups compared with the control group. However, abnormalities in eosinophil populations were not observed. In vitro activation of whole blood with fMLP caused similar changes in neutrophil light scatter, suggesting that neutrophil activation is present in peripheral blood of symptomatic asthmatic patients. IL-8 caused a change in shape of the neutrophils seen using transmission electron microscopy.
CONCLUSIONS---Evidence of neutrophil activation can be seen in whole blood from patients with asthma using a novel automated method. This may potentially be applied to other inflammatory diseases.


Keywords: asthma; neutrophil activation; automated method

© 2000 by Thorax




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 BMJ Publishing Group Ltd & British Thoracic Society